We can't find the internet
Attempting to reconnect
15610.1 PFLS-LS
15610.1 PFLS-LS
Résumé
Development of a recently validated cell penetrating peptide into an efficacious therapeutic cancer vaccine
Textes supplémentaires
Abstract
Therapeutic cancer vaccines are becoming an attractive approach that can be combined with standard of care to treat cancer patients. The patient immune system is educated to specifically recognize and destroy tumor cells. This project aims at designing and optimizing an immunization strategy for a new cancer vaccine including the vector, the antigen and the choice of adjuvant. Finally, the proof-of-concept will be performed in a murine model of brain tumors.
Participants
Madiha Derouazi
Wirtschaftspartner
madiha.derouazi@amaltherapeutics.com
Amal Therapeutics SA Madiha Derouazi Avenue de la Roseraie 64 1205 Genève GE CH
Paul Walker
Kontaktperson
Paul.Walker@hcuge.ch
Université de Genève Paul Walker Rue Gabrielle-Perret-Gentil 4 1211 Genève GE CH
Détails du projet
- Office de recherche
- INNOSUISSE
- Statut du projet
- Abgeschlossen
- Type de projet
- Forschungsprojekt
- Date de début
- 2013-07-31
- Date de fin
- 2015-10-31
- Coûts totaux approuvés
- CHF 488704.00
- Section
- 20 Förderbereich Life Sciences
- Domaine politique NABS
- Industrielle Produktivität und Technologie
Disciplines de recherche
- T490 Biotechnology 100.0%